Tapewire

Nasdaq · USD

LAB

STANDARD BIOTOOLS INC.

Export transactions ↓
Tapewire entity
6116
SEC CIK
0001162194
Parsed reports
516

Last 12 months

Inside the activity.

15 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025120
Dec 202530
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 20, 2022 Filed May 24, 2022 00:16 UTC
Kreger Bradley AllenSVP, Global Operations
Exercise / conversionCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000061 · wf-form4_165335137558591.xml · nonDerivative · entry 4

Kreger Bradley Allen · CIK 0001739205 · SVP, Global Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,061

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 20, 2022 Filed May 24, 2022 00:16 UTC
Kreger Bradley AllenSVP, Global Operations
Exercise / conversionCommon Stock 2,391 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000061 · wf-form4_165335137558591.xml · nonDerivative · entry 3

Kreger Bradley Allen · CIK 0001739205 · SVP, Global Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,061

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 20, 2022 Filed May 24, 2022 00:16 UTC
Kreger Bradley AllenSVP, Global Operations
Exercise / conversionCommon Stock 2,237 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000061 · wf-form4_165335137558591.xml · nonDerivative · entry 2

Kreger Bradley Allen · CIK 0001739205 · SVP, Global Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,670

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 20, 2022 Filed May 24, 2022 00:16 UTC
Kreger Bradley AllenSVP, Global Operations
Exercise / conversionCommon Stock 3,125 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000061 · wf-form4_165335137558591.xml · nonDerivative · entry 1

Kreger Bradley Allen · CIK 0001739205 · SVP, Global Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,433

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 20, 2022 Filed May 24, 2022 00:15 UTC
JOG VIKRAMChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 12,522 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000059 · wf-form4_165335133249488.xml · derivative · entry 12

JOG VIKRAM · CIK 0001222641 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,567

Underlying: Common Stock · 12,522 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.

F7 · derivative.exercise_date: On April 20, 2021, the Reporting Person was granted 50,089 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter.

F7 · derivative.expiration_date: On April 20, 2021, the Reporting Person was granted 50,089 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter.

Read SEC document
May 20, 2022 Filed May 24, 2022 00:15 UTC
JOG VIKRAMChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 22,500 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000059 · wf-form4_165335133249488.xml · derivative · entry 11

JOG VIKRAM · CIK 0001222641 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Common Stock · 22,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.

F6 · derivative.exercise_date: On May 23, 2020, the Reporting Person was granted 90,000 Restricted Stock Units vesting as to 1/2 of the total number of shares on May 20, 2021, and as to 1/4th of the total number of shares on each of May 20, 2022 and May 20, 2023.

F6 · derivative.expiration_date: On May 23, 2020, the Reporting Person was granted 90,000 Restricted Stock Units vesting as to 1/2 of the total number of shares on May 20, 2021, and as to 1/4th of the total number of shares on each of May 20, 2022 and May 20, 2023.

Read SEC document
May 20, 2022 Filed May 24, 2022 00:15 UTC
JOG VIKRAMChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 2,391 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000059 · wf-form4_165335133249488.xml · derivative · entry 10

JOG VIKRAM · CIK 0001222641 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,735

Underlying: Common Stock · 2,391 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.

F5 · derivative.exercise_date: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.

F5 · derivative.expiration_date: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.

Read SEC document
May 20, 2022 Filed May 24, 2022 00:15 UTC
JOG VIKRAMChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 2,237 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000059 · wf-form4_165335133249488.xml · derivative · entry 9

JOG VIKRAM · CIK 0001222641 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,711

Underlying: Common Stock · 2,237 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.

F4 · derivative.exercise_date: On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

F4 · derivative.expiration_date: On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

Read SEC document
May 20, 2022 Filed May 24, 2022 00:15 UTC
JOG VIKRAMChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 2,251 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000059 · wf-form4_165335133249488.xml · derivative · entry 8

JOG VIKRAM · CIK 0001222641 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,251 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.

F3 · derivative.exercise_date: On June 11, 2018, the Reporting Person was granted 36,016 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and 1/16th of the total number of shares each quarter thereafter.

F3 · derivative.expiration_date: On June 11, 2018, the Reporting Person was granted 36,016 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and 1/16th of the total number of shares each quarter thereafter.

Read SEC document
May 20, 2022 Filed May 24, 2022 00:15 UTC
JOG VIKRAMChief Financial Officer
Tax withholdingCommon Stock 14,361 $2.05 $29,440.05
Disclosure

SEC source: 0001162194-22-000059 · wf-form4_165335133249488.xml · nonDerivative · entry 6

JOG VIKRAM · CIK 0001222641 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 161,751

Read SEC document
May 20, 2022 Filed May 24, 2022 00:15 UTC
JOG VIKRAMChief Financial Officer
Exercise / conversionCommon Stock 12,522 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000059 · wf-form4_165335133249488.xml · nonDerivative · entry 5

JOG VIKRAM · CIK 0001222641 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 176,112

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 20, 2022 Filed May 24, 2022 00:15 UTC
JOG VIKRAMChief Financial Officer
Exercise / conversionCommon Stock 22,500 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000059 · wf-form4_165335133249488.xml · nonDerivative · entry 4

JOG VIKRAM · CIK 0001222641 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 163,590

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 20, 2022 Filed May 24, 2022 00:15 UTC
JOG VIKRAMChief Financial Officer
Exercise / conversionCommon Stock 2,391 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000059 · wf-form4_165335133249488.xml · nonDerivative · entry 3

JOG VIKRAM · CIK 0001222641 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 141,090

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 20, 2022 Filed May 24, 2022 00:15 UTC
JOG VIKRAMChief Financial Officer
Exercise / conversionCommon Stock 2,237 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000059 · wf-form4_165335133249488.xml · nonDerivative · entry 2

JOG VIKRAM · CIK 0001222641 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 138,699

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 20, 2022 Filed May 24, 2022 00:15 UTC
JOG VIKRAMChief Financial Officer
Exercise / conversionCommon Stock 2,251 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000059 · wf-form4_165335133249488.xml · nonDerivative · entry 1

JOG VIKRAM · CIK 0001222641 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,462

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 20, 2022 Filed May 24, 2022 00:16 UTC
Khadder NicholasSVP, Gen. Counsel & Secretary
Exercise / conversionRestricted Stock Units · Derivative 9,846 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000060 · wf-form4_165335135061773.xml · derivative · entry 7

Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,541

Underlying: Common Stock · 9,846 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.

F4 · derivative.exercise_date: On April 20, 2021, the Reporting Person was granted 39,387 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter.

F4 · derivative.expiration_date: On April 20, 2021, the Reporting Person was granted 39,387 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter.

Read SEC document
May 20, 2022 Filed May 24, 2022 00:16 UTC
Khadder NicholasSVP, Gen. Counsel & Secretary
Exercise / conversionRestricted Stock Units · Derivative 15,000 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000060 · wf-form4_165335135061773.xml · derivative · entry 6

Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.

F3 · derivative.exercise_date: On May 23, 2020, the Reporting Person was granted 60,000 Restricted Stock Units vesting as to 1/2 of the total number of shares on May 20, 2021, and as to 1/4th of the total number of shares on each of May 20, 2022 and May 20, 2023.

F3 · derivative.expiration_date: On May 23, 2020, the Reporting Person was granted 60,000 Restricted Stock Units vesting as to 1/2 of the total number of shares on May 20, 2021, and as to 1/4th of the total number of shares on each of May 20, 2022 and May 20, 2023.

Read SEC document
May 20, 2022 Filed May 24, 2022 00:16 UTC
Khadder NicholasSVP, Gen. Counsel & Secretary
Exercise / conversionRestricted Stock Units · Derivative 4,063 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000060 · wf-form4_165335135061773.xml · derivative · entry 5

Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,500

Underlying: Common Stock · 4,063 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.

F2 · derivative.exercise_date: On May 23, 2020, the Reporting Person was granted 65,000 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.

F2 · derivative.expiration_date: On May 23, 2020, the Reporting Person was granted 65,000 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.

Read SEC document
May 20, 2022 Filed May 24, 2022 00:16 UTC
Khadder NicholasSVP, Gen. Counsel & Secretary
Tax withholdingCommon Stock 14,161 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000060 · wf-form4_165335135061773.xml · nonDerivative · entry 4

Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,139

Read SEC document
May 20, 2022 Filed May 24, 2022 00:16 UTC
Khadder NicholasSVP, Gen. Counsel & Secretary
Exercise / conversionCommon Stock 9,846 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000060 · wf-form4_165335135061773.xml · nonDerivative · entry 3

Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,300

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 20, 2022 Filed May 24, 2022 00:16 UTC
Khadder NicholasSVP, Gen. Counsel & Secretary
Exercise / conversionCommon Stock 15,000 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000060 · wf-form4_165335135061773.xml · nonDerivative · entry 2

Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,454

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 20, 2022 Filed May 24, 2022 00:16 UTC
Khadder NicholasSVP, Gen. Counsel & Secretary
Exercise / conversionCommon Stock 4,063 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000060 · wf-form4_165335135061773.xml · nonDerivative · entry 1

Khadder Nicholas · CIK 0001598911 · SVP, Gen. Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,454

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 10, 2022 Filed May 11, 2022 01:03 UTC PurchaseCommon Stock 25,000 $2.52 $63,000.00
Disclosure

SEC source: 0000902664-22-002849 · ownership.xml · nonDerivative · entry 2

Caligan Partners LP · CIK 0001727492 · 10% owner

JOHNSON DAVID EDWARD · CIK 0001785557 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 9,973,188

F1 · price: The securities reported herein are held by an affiliated fund and managed account of Caligan Partners LP ("Caligan"). David Johnson (together with Caligan, the "Reporting Persons") is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan.

F2 · ownership.nature: The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price.

Read SEC document
May 06, 2022 Filed May 11, 2022 01:03 UTC PurchaseCommon Stock, $0.001 par value per share (Common Stock) 463,350 $2.90 $1,343,715.00
Disclosure

SEC source: 0000902664-22-002849 · ownership.xml · nonDerivative · entry 1

Caligan Partners LP · CIK 0001727492 · 10% owner

JOHNSON DAVID EDWARD · CIK 0001785557 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 9,948,188

F1 · price: The securities reported herein are held by an affiliated fund and managed account of Caligan Partners LP ("Caligan"). David Johnson (together with Caligan, the "Reporting Persons") is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan.

F2 · ownership.nature: The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price.

Read SEC document
May 02, 2022 Filed May 2, 2022 23:44 UTC PurchaseCommon Stock 125,000 $2.81 $351,250.00
Disclosure

SEC source: 0000902664-22-002740 · ownership.xml · nonDerivative · entry 3

Caligan Partners LP · CIK 0001727492 · 10% owner

JOHNSON DAVID EDWARD · CIK 0001785557 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 9,484,838

F4 · price: Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date for prices ranging from $ 2.71 to $2.89.

F5 · price: The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: The securities reported herein are held by an affiliated fund and managed account of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan.

Read SEC document
April 29, 2022 Filed May 2, 2022 23:44 UTC PurchaseCommon Stock 247,400 $2.66 $658,084.00
Disclosure

SEC source: 0000902664-22-002740 · ownership.xml · nonDerivative · entry 2

Caligan Partners LP · CIK 0001727492 · 10% owner

JOHNSON DAVID EDWARD · CIK 0001785557 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 9,359,838

F3 · price: Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date for prices ranging from $2.57 to $2.70.

F5 · price: The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: The securities reported herein are held by an affiliated fund and managed account of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan.

Read SEC document
April 28, 2022 Filed May 2, 2022 23:44 UTC PurchaseCommon Stock, $0.001 par value per share ("Common Stock") 27,600 $2.40 $66,240.00
Disclosure

SEC source: 0000902664-22-002740 · ownership.xml · nonDerivative · entry 1

Caligan Partners LP · CIK 0001727492 · 10% owner

JOHNSON DAVID EDWARD · CIK 0001785557 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 9,112,438

F1 · price: Price is the volume weighted average selling price of all sales by Caligan Partners LP ("Caligan") and David Johnson (together with Caligan, the "Reporting Persons") on the transaction date for prices ranging from $2.37 to $2.44.

F5 · price: The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: The securities reported herein are held by an affiliated fund and managed account of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan.

Read SEC document
April 20, 2022 Filed Apr 21, 2022 22:21 UTC
Davis Jeremy StevenSVP Chief Commercial Officer
GrantRestricted Stock Units · Derivative 250,000 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000047 · wf-form4_165057963638945.xml · derivative · entry 1

Davis Jeremy Steven · CIK 0001919871 · SVP Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.

F2 · derivative.exercise_date: Restricted Stock Units vest as to 1/4th of the underlying shares on May 20, 2023, and as to an additional 1/16th of the total number of shares each quarter thereafter.

F2 · derivative.expiration_date: Restricted Stock Units vest as to 1/4th of the underlying shares on May 20, 2023, and as to an additional 1/16th of the total number of shares each quarter thereafter.

Read SEC document
April 12, 2022 Filed Apr 13, 2022 20:27 UTC PurchaseCommon Stock 50,000 $3.60 $180,000.00
Disclosure

SEC source: 0000902664-22-002542 · ownership.xml · nonDerivative · entry 2

Caligan Partners LP · CIK 0001727492 · 10% owner

JOHNSON DAVID EDWARD · CIK 0001785557 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 9,084,838

F1 · ownership.nature: The securities reported herein are held by an affiliated fund and managed account of Caligan Partners LP ("Caligan"). David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan.

Read SEC document
April 11, 2022 Filed Apr 13, 2022 20:27 UTC PurchaseCommon Stock, $0.001 par value per share ("Common Stock") 145,000 $3.87 $561,150.00
Disclosure

SEC source: 0000902664-22-002542 · ownership.xml · nonDerivative · entry 1

Caligan Partners LP · CIK 0001727492 · 10% owner

JOHNSON DAVID EDWARD · CIK 0001785557 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 9,034,838

F1 · ownership.nature: The securities reported herein are held by an affiliated fund and managed account of Caligan Partners LP ("Caligan"). David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan.

Read SEC document
April 08, 2022 Filed Apr 8, 2022 21:19 UTC PurchaseCommon Stock 200,000 $3.76 $752,000.00
Disclosure

SEC source: 0000902664-22-002486 · ownership.xml · nonDerivative · entry 3

Caligan Partners LP · CIK 0001727492 · 10% owner

JOHNSON DAVID EDWARD · CIK 0001785557 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 8,889,838

F1 · ownership.nature: The securities reported herein are held by an affiliated fund and managed account of Caligan Partners LP ("Caligan"). David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan.

Read SEC document
April 07, 2022 Filed Apr 8, 2022 21:19 UTC PurchaseCommon Stock 200,000 $3.88 $776,000.00
Disclosure

SEC source: 0000902664-22-002486 · ownership.xml · nonDerivative · entry 2

Caligan Partners LP · CIK 0001727492 · 10% owner

JOHNSON DAVID EDWARD · CIK 0001785557 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 8,689,838

F1 · ownership.nature: The securities reported herein are held by an affiliated fund and managed account of Caligan Partners LP ("Caligan"). David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan.

Read SEC document
April 06, 2022 Filed Apr 8, 2022 21:19 UTC PurchaseCommon Stock, $0.001 par value per share ("Common Stock") 109,573 $3.60 $394,462.80
Disclosure

SEC source: 0000902664-22-002486 · ownership.xml · nonDerivative · entry 1

Caligan Partners LP · CIK 0001727492 · 10% owner

JOHNSON DAVID EDWARD · CIK 0001785557 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 8,489,838

F1 · ownership.nature: The securities reported herein are held by an affiliated fund and managed account of Caligan Partners LP ("Caligan"). David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan.

Read SEC document
April 04, 2022 Filed Apr 6, 2022 22:35 UTC
Kim Hanjoon AlexChief Operating Officer
GrantStock Option (Right to Buy) · Derivative 1,617,775 $0.00 Strike: $3.99 $0.00
Disclosure

SEC source: 0001162194-22-000044 · wf-form4_164928452937903.xml · derivative · entry 2

Kim Hanjoon Alex · CIK 0001919209 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,617,775

Underlying: Common Stock · 1,617,775 shares

Expires 2032-04-04

F3 · derivative.exercise_date: The Option becomes exercisable as to 1/4th of the underlying shares on April 4, 2023, and as to an additional 1/48th of the total number of shares each month thereafter.

Read SEC document
April 04, 2022 Filed Apr 6, 2022 22:35 UTC
Kim Hanjoon AlexChief Operating Officer
GrantRestricted Stock Units · Derivative 280,732 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000044 · wf-form4_164928452937903.xml · derivative · entry 1

Kim Hanjoon Alex · CIK 0001919209 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 280,732

Underlying: Common Stock · 280,732 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F2 · derivative.exercise_date: Restricted Stock Units vest in four equal annual installments beginning April 4, 2023.

F2 · derivative.expiration_date: Restricted Stock Units vest in four equal annual installments beginning April 4, 2023.

Read SEC document
April 04, 2022 Filed Apr 6, 2022 22:35 UTC GrantStock Option (Right to Buy) · Derivative 23,401 $0.00 Strike: $3.99 $0.00
Disclosure

SEC source: 0001162194-22-000042 · wf-form4_164928449407109.xml · derivative · entry 2

Madaus Martin D · CIK 0001310268 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,401

Underlying: Common Stock · 23,401 shares

Expires 2032-04-04

F2 · derivative.exercise_date: The Option becomes exercisable in four equal annual installments beginning on April 4, 2023.

Read SEC document
April 04, 2022 Filed Apr 6, 2022 22:35 UTC GrantCommon Stock 15,852 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000042 · wf-form4_164928449407109.xml · nonDerivative · entry 1

Madaus Martin D · CIK 0001310268 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,852

F1 · shares: Represents Restricted Stock Units that vest in four equal annual installments beginning April 4, 2023.

Read SEC document
April 04, 2022 Filed Apr 6, 2022 22:35 UTC
Egholm MichaelDirector · President & CEO
GrantStock Option (Right to Buy) · Derivative 4,529,773 $0.00 Strike: $3.99 $0.00
Disclosure

SEC source: 0001162194-22-000045 · wf-form4_164928454559915.xml · derivative · entry 2

Egholm Michael · CIK 0001559779 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,529,773

Underlying: Common Stock · 4,529,773 shares

Expires 2032-04-04

F3 · derivative.exercise_date: The Option becomes exercisable as to 1/4th of the underlying shares on April 4, 2023, and as to an additional 1/48th of the total number of shares each month thereafter.

Read SEC document
April 04, 2022 Filed Apr 6, 2022 22:35 UTC
Egholm MichaelDirector · President & CEO
GrantRestricted Stock Units · Derivative 786,049 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000045 · wf-form4_164928454559915.xml · derivative · entry 1

Egholm Michael · CIK 0001559779 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 786,049

Underlying: Common Stock · 786,049 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F2 · derivative.exercise_date: Restricted Stock Units vest in four equal annual installments beginning April 4, 2023.

F2 · derivative.expiration_date: Restricted Stock Units vest in four equal annual installments beginning April 4, 2023.

Read SEC document
April 04, 2022 Filed Apr 6, 2022 22:35 UTC
Witney FrankDirector
GrantStock Option (Right to Buy) · Derivative 23,401 $0.00 Strike: $3.99 $0.00
Disclosure

SEC source: 0001162194-22-000043 · wf-form4_164928451242882.xml · derivative · entry 3

Witney Frank · CIK 0001455312 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,401

Underlying: Common Stock · 23,401 shares

Expires 2032-04-04

F3 · derivative.exercise_date: The Option becomes exercisable in four equal annual installments beginning on April 4, 2023.

Read SEC document
April 04, 2022 Filed Apr 6, 2022 22:35 UTC
Witney FrankDirector
GrantCommon Stock 15,852 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000043 · wf-form4_164928451242882.xml · nonDerivative · entry 1

Witney Frank · CIK 0001455312 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,852

F1 · shares: Represents Restricted Stock Units that vest in four equal annual installments beginning April 4, 2023.

Read SEC document
April 04, 2022 Filed Apr 6, 2022 21:54 UTC
Casdin Capital, LLCDirector · 10% owner
Casdin Partners GP, LLCDirector · 10% owner
GrantSeries B-1 Convertible Preferred Stock · Derivative 127,780 Not disclosed Not disclosed
Disclosure

SEC source: 0000950142-22-001325 · es220241789_4-lab.xml · derivative · entry 1

Casdin Partners Master Fund, L.P. · CIK 0001534265 · Director · 10% owner

Casdin Capital, LLC · CIK 0001534261 · Director · 10% owner

Casdin Partners GP, LLC · CIK 0001534260 · Director · 10% owner

Casdin Private Growth Equity Fund II, L.P. · CIK 0001891102 · Director · 10% owner

Casdin Private Growth Equity Fund II GP, LLC · CIK 0001919480 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,780

Underlying: Common Stock · 37,582,346 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of the Issuer's Series B-1 Convertible Preferred Stock (the "Series B-1 Preferred Stock") is convertible at the option of the Reporting Person at any time into a number of shares of the Issuer's common stock, par value $0.001 per share, equal to the conversion rate, which is initially 294.1176, subject to certain anti-dilution adjustments and limitations on conversion pursuant to the Certificate of Designation for the Series B-1 Preferred Stock.

F2 · price: On April 4, 2022, the Issuer issued the Series B-1 Preferred Stock (i) in exchange for aggregate cash consideration of $112.5 million, pursuant to the Series B-1 Convertible Preferred Stock Purchase Agreement, dated as of January 23, 2022, among the Issuer, Casdin Partners Master Fund, L.P. ("Casdin Master Fund") and Casdin Private Growth Equity Fund II, L.P. ("Casdin Private Growth Fund") and (ii) upon the conversion of $12.5 million aggregate principal amount of term loans, including accrued and unpaid interest, pursuant to the Series B-1 Loan Agreement, dated as of January 23, 2022, among the Issuer, Casdin Master Fund and Casdin Private Growth Fund.

F1 · derivative.exercise_date: Each share of the Issuer's Series B-1 Convertible Preferred Stock (the "Series B-1 Preferred Stock") is convertible at the option of the Reporting Person at any time into a number of shares of the Issuer's common stock, par value $0.001 per share, equal to the conversion rate, which is initially 294.1176, subject to certain anti-dilution adjustments and limitations on conversion pursuant to the Certificate of Designation for the Series B-1 Preferred Stock.

F1 · derivative.expiration_date: Each share of the Issuer's Series B-1 Convertible Preferred Stock (the "Series B-1 Preferred Stock") is convertible at the option of the Reporting Person at any time into a number of shares of the Issuer's common stock, par value $0.001 per share, equal to the conversion rate, which is initially 294.1176, subject to certain anti-dilution adjustments and limitations on conversion pursuant to the Certificate of Designation for the Series B-1 Preferred Stock.

F1 · derivative.underlying_shares: Each share of the Issuer's Series B-1 Convertible Preferred Stock (the "Series B-1 Preferred Stock") is convertible at the option of the Reporting Person at any time into a number of shares of the Issuer's common stock, par value $0.001 per share, equal to the conversion rate, which is initially 294.1176, subject to certain anti-dilution adjustments and limitations on conversion pursuant to the Certificate of Designation for the Series B-1 Preferred Stock.

F3 · ownership.direct: These shares are held by Casdin Master Fund and Casdin Private Growth Fund. Casdin Capital, LLC ("Casdin Capital") is the investment adviser to Casdin Master Fund and Casdin Private Growth Fund. Casdin Partners GP, LLC ("Casdin Partners GP") is the general partner of Casdin Master Fund and Casdin Private Growth Equity Fund II GP, LLC ("Casdin Private Growth GP") is the general partner of Casdin Private Growth Fund. Eli Casdin is the managing member of Casdin Capital, Casdin Partners GP and Casdin Private Growth GP. Each of Casdin Capital, Casdin Partners GP, Casdin Private Growth GP and Eli Casdin disclaims beneficial ownership of such securities except to the extent of their respective pecuniary interest therein, if any.

Read SEC document
April 04, 2022 Filed Apr 6, 2022 21:54 UTC
Casdin EliDirector · 10% owner
GrantStock Option (Right to Buy) · Derivative 23,401 $0.00 Strike: $3.99 $0.00
Disclosure

SEC source: 0000950142-22-001324 · es220241790_4-eclab.xml · derivative · entry 3

Casdin Eli · CIK 0001534264 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,401

Underlying: Common Stock · 23,401 shares

Expires 2032-04-04

F5 · derivative.exercise_date: The Option becomes exercisable in four equal annual increments beginning on April 4, 2023.

Read SEC document
April 04, 2022 Filed Apr 6, 2022 21:54 UTC
Casdin EliDirector · 10% owner
GrantSeries B-1 Convertible Preferred Stock · Derivative 127,780 Not disclosed Not disclosed
Disclosure

SEC source: 0000950142-22-001324 · es220241790_4-eclab.xml · derivative · entry 2

Casdin Eli · CIK 0001534264 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 127,780

Underlying: Common Stock · 37,582,346 shares

Expires not disclosed

F2 · derivative.exercise_price: Each share of the Issuer's Series B-1 Convertible Preferred Stock (the "Series B-1 Preferred Stock") is convertible at the option of the Reporting Person at any time into a number of shares of the Issuer's common stock, par value $0.001 per share, equal to the conversion rate, which is initially 294.1176, subject to certain anti-dilution adjustments and limitations on conversion pursuant to the Certificate of Designation for the Series B-1 Preferred Stock.

F3 · price: On April 4, 2022, the Issuer issued the Series B-1 Preferred Stock (i) in exchange for aggregate cash consideration of $112.5 million, pursuant to the Series B-1 Convertible Preferred Stock Purchase Agreement, dated as of January 23, 2022, among the Issuer, Casdin Partners Master Fund, L.P. ("Casdin Master Fund") and Casdin Private Growth Equity Fund II, L.P. ("Casdin Private Growth Fund") and (ii) upon the conversion of $12.5 million aggregate principal amount of term loans, including accrued and unpaid interest, pursuant to the Series B-1 Loan Agreement, dated as of January 23, 2022, among the Issuer, Casdin Master Fund and Casdin Private Growth Fund.

F2 · derivative.exercise_date: Each share of the Issuer's Series B-1 Convertible Preferred Stock (the "Series B-1 Preferred Stock") is convertible at the option of the Reporting Person at any time into a number of shares of the Issuer's common stock, par value $0.001 per share, equal to the conversion rate, which is initially 294.1176, subject to certain anti-dilution adjustments and limitations on conversion pursuant to the Certificate of Designation for the Series B-1 Preferred Stock.

F2 · derivative.expiration_date: Each share of the Issuer's Series B-1 Convertible Preferred Stock (the "Series B-1 Preferred Stock") is convertible at the option of the Reporting Person at any time into a number of shares of the Issuer's common stock, par value $0.001 per share, equal to the conversion rate, which is initially 294.1176, subject to certain anti-dilution adjustments and limitations on conversion pursuant to the Certificate of Designation for the Series B-1 Preferred Stock.

F2 · derivative.underlying_shares: Each share of the Issuer's Series B-1 Convertible Preferred Stock (the "Series B-1 Preferred Stock") is convertible at the option of the Reporting Person at any time into a number of shares of the Issuer's common stock, par value $0.001 per share, equal to the conversion rate, which is initially 294.1176, subject to certain anti-dilution adjustments and limitations on conversion pursuant to the Certificate of Designation for the Series B-1 Preferred Stock.

F4 · ownership.nature: These shares are held by Casdin Master Fund and Casdin Private Growth Fund. Casdin Capital, LLC ("Casdin Capital") is the investment adviser to Casdin Master Fund and Casdin Private Growth Fund. Casdin Partners GP, LLC ("Casdin Partners GP") is the general partner of Casdin Master Fund and Casdin Private Growth Equity Fund II GP, LLC ("Casdin Private Growth GP") is the general partner of Casdin Private Growth Fund. Eli Casdin is the managing member of Casdin Capital, Casdin Partners GP and Casdin Private Growth GP. Each of Casdin Capital, Casdin Partners GP, Casdin Private Growth GP and Eli Casdin disclaims beneficial ownership of such securities except to the extent of their respective pecuniary interest therein, if any.

Read SEC document
April 04, 2022 Filed Apr 6, 2022 21:54 UTC
Casdin EliDirector · 10% owner
GrantCommon Stock 15,852 $0.00 $0.00
Disclosure

SEC source: 0000950142-22-001324 · es220241790_4-eclab.xml · nonDerivative · entry 1

Casdin Eli · CIK 0001534264 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,852

F1 · shares: Represents Restricted Stock Units that vest in four equal annual increments beginning April 4, 2023.

Read SEC document
April 01, 2022 Filed Apr 4, 2022 20:16 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 20,993 $3.74 Strike: $3.74 $78,513.82
Disclosure

SEC source: 0001162194-22-000027 · wf-form4_164910337858688.xml · derivative · entry 2

BARTHELEMY NICOLAS · CIK 0001283576 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,993 shares

Expires 2030-06-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 01, 2022 Filed Apr 4, 2022 20:16 UTC Exercise / conversionCommon Stock 20,993 $3.74 $78,513.82
Disclosure

SEC source: 0001162194-22-000027 · wf-form4_164910337858688.xml · nonDerivative · entry 1

BARTHELEMY NICOLAS · CIK 0001283576 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · The Barthelemy 2001 Trust

Disclosed balance after: 204,077

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 31, 2022 Filed Apr 2, 2022 00:31 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $3.43 Strike: $3.43 $17,150.00
Disclosure

SEC source: 0001162194-22-000025 · wf-form4_164885945022114.xml · derivative · entry 2

BARTHELEMY NICOLAS · CIK 0001283576 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2027-08-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 31, 2022 Filed Apr 2, 2022 00:31 UTC Exercise / conversionCommon Stock 5,000 $3.43 $17,150.00
Disclosure

SEC source: 0001162194-22-000025 · wf-form4_164885945022114.xml · nonDerivative · entry 1

BARTHELEMY NICOLAS · CIK 0001283576 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · The Barthelemy 2001 Trust

Disclosed balance after: 183,084

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 22, 2022 Filed Feb 24, 2022 22:18 UTC
Kreger Bradley AllenSVP, Global Operations
Exercise / conversionRestricted Stock Units · Derivative 3,125 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000018 · wf-form4_164574109291523.xml · derivative · entry 7

Kreger Bradley Allen · CIK 0001739205 · SVP, Global Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,125

Underlying: Common Stock · 3,125 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F4 · derivative.exercise_date: On April 30, 2018, the Reporting Person was granted 50,000 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2019, and as to 1/16th of the total number of shares each quarter thereafter.

F4 · derivative.expiration_date: On April 30, 2018, the Reporting Person was granted 50,000 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2019, and as to 1/16th of the total number of shares each quarter thereafter.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.